Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Randomized comparison of three biopsy needles for diagnosing solid pancreatic masses

Official title: Prospective Randomized Controlled Trial Comparing Accuracy Among Franseen, Forward-bevel Westcott, and Fork-tip Needle Design for EUS-guided Fine Needle Biopsy in Diagnosis of Solid Pancreatic Lesions

Run by Mahidol University · NCT07032974 · Data updated 2026-11-12

This test will see if three different endoscopic ultrasound biopsy needles (Franseen, forward-bevel/Westcott, and fork-tip) get better tissue samples for adults with solid pancreatic masses who need a diagnosis.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment108 (estimated)
SponsorMahidol University
Academic / other
Locations1 site (Bangkok, Bangkok)
StatusRecruiting
StartedJuly 1, 2025
Main results expectedJuly 2026
Study endsJuly 2026
Registry record updatedJune 24, 2025
Trial IDNCT07032974 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with a solid pancreatic mass at least 1 cm in size who require tissue diagnosis and can give informed consent are ideal candidates.

Probably not a fit

Patients with cystic lesions, masses under 1 cm, pregnancy, uncorrected bleeding disorders, or surgically altered anatomy may not benefit or may be ineligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized interventional trial, adults with solid pancreatic masses ≥1 cm will undergo EUS-guided tissue sampling with one of three FNB needle types (Franseen, forward-bevel/Westcott, or fork-tip). The primary focus is on diagnostic accuracy and sample adequacy, with secondary endpoints including number of needle passes, need for rapid on-site evaluation (ROSE), and procedure-related adverse events. Key exclusions include pregnancy, uncorrected coagulopathy, and surgically altered anatomy. All procedures and pathology evaluation are conducted at the Faculty of Medicine Siriraj Hospital, Mahidol University in Bangkok.

Why it matters

Potential benefit: If successful, the best-performing needle could improve diagnostic accuracy, provide larger histologic samples, reduce the number of passes and need for on-site cytology, and speed treatment decisions.

How similar studies have gone: Previous studies have shown that FNB needle designs (including Franseen and fork-tip) often yield better tissue cores and histologic diagnostic rates than standard FNA, but direct randomized comparisons among these three specific needles are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \> 18 years
* Solid pancreatic mass greater than 1 cm in size who required tissue diagnosis

Exclusion Criteria:

* Pregnancy
* Uncorrected coagulopathy
* Surgically altered anatomy
* Unable to complete informed consent

Where it's running

  • Faculty of Medicine Siriraj Hospital, Mahidol University
    Bangkok, Bangkok, Thailand
    Recruiting

Study contacts

  • Principal investigator: Varayu Prachayakul, MD — Siriraj Hospital
  • Study coordinator: Ronnakorn Kongsakon, MD
  • Email: ronnagorn@gmail.com
  • Phone: +66655979522

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.